| Adjusted | Adjusting | Statutory | Adjusted | Adjusting | Statutory | ||
| total | items | total | total | items | total | ||
| 2025 | 2025 | 2025 | 2024 | 2024 | 2024 | ||
from continuing operations | notes | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
Revenue | 2 | ||||||
Cost of sales | 4 | ( | ( | ( | ( | ( | |
Gross profit | ( | ||||||
Distribution costs | ( | ( | ( | ( | |||
Administrative expenses | ( | ( | ( | ( | |||
Operating profit | ( | ||||||
Financial income | 5 | ||||||
Financial expenses | 5 | ( | ( | ( | ( | ( | |
Shareofprofitsofjointventures | 13 | ||||||
Profit before tax | ( | ||||||
Income tax expense | 7 | ( | ( | ( | ( | ( | |
Profit for the year | ( | ||||||
| Profit attributable to: | |||||||
Equity shareholders of the parent company | |||||||
Non-controlling interest | 26 | ||||||
Profitfortheyear | |||||||
pence | pence | pence | pence | pence | pence | ||
Dividend per share arising in respect of the year | 26 | ||||||
Dividend per share paid in the year | 26 | ||||||
Earningspershare(basicanddiluted) | 8 | ( |
| Adjusted | Adjusting | Statutory | |||||
| Adjusted | Adjusting | Statutory | total | items | total | ||
| total | items | total | 2024 | 2024 | 2024 | ||
| 2025 | 2025 | 2025 | (restated) | (restated) | (restated) | ||
| notes | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Profit for the year | ( | ||||||
| Other items recognised directly in equity: | |||||||
Items that will not be reclassified to the Consolidated income statement: | |||||||
| Remeasurementofdefinedbenefitpensionscheme | |||||||
assets/liabilities/reimbursement right | 23 | ( | ( | ||||
| Deferredtaxonremeasurementofdefinedbenefit | |||||||
pension scheme assets/liabilities/reimbursement right | ( | ( | |||||
Total for items that will not be reclassified | ( | ( | |||||
| Items that may be reclassified to the Consolidated | |||||||
| income statement: | |||||||
| Exchangedifferencesintranslationof | |||||||
overseasoperations | 26 | ( | ( | ( | ( | ||
| Exchangedifferencesintranslationofoverseas | |||||||
jointventure | 26 | ( | ( | ||||
Current tax on translation of net investments in overseas operations | 26 | ||||||
| Effectiveportionofchangesinfairvalueofcashflow | |||||||
hedges,netofrecycling | 26 | ||||||
| Deferredtaxoneffectiveportionofchangesinfair | |||||||
valueofcashflowhedges | 7,26 | ( | ( | ( | ( | ||
Total for items that may be reclassified | ( | ( | |||||
Total other comprehensive income and expense, net of tax | ( | ( | |||||
Total comprehensive income and expense for theyear | ( | ||||||
| Attributable to: | |||||||
Equity shareholders of the parent company | |||||||
Non-controlling interest | 26 | ||||||
Total comprehensive income and expense for theyear |
| 2024 | 2023 | |||
| 2025 | (restated) | (restated) | ||
| notes | £’000 | £’000 | £’000 | |
| Assets | ||||
Property,plantandequipment | 9 | |||
Right-of-use assets | 10 | |||
Investment properties | 11 | |||
Intangible assets | 12 | |||
Investmentsinjointventures | 13 | |||
Finance lease receivables | 14 | |||
Employeebenefits | 23 | |||
Reimbursement right | 23 | |||
Deferred tax assets | 7 | |||
Derivatives | 25 | |||
Total non-current assets | ||||
| Current assets | ||||
Inventories | 16 | |||
Trade receivables | 25 | |||
Finance lease receivables | 14 | |||
Current tax | ||||
Other receivables | 25 | |||
Derivatives | 25 | |||
| Bank deposits | 15,25 | |||
| Cash and cash equivalents | 15,25 | |||
Total current assets | ||||
| Current liabilities | ||||
Trade payables | 25 | |||
Contract liabilities | 18 | |||
Current tax | ||||
Provisions | 17 | |||
Derivatives | 25 | |||
Lease liabilities | 21 | |||
Amountspayabletojointventure | 13 | |||
Borrowings | 20 | |||
Other payables | 19 | |||
Total current liabilities | ||||
Net current assets | ||||
| Non-current liabilities | ||||
Lease liabilities | 21 | |||
Borrowings | 20 | |||
Employeebenefits | 23 | |||
Deferred tax liabilities | 7 | |||
Derivatives | 25 | |||
Total non-current liabilities | ||||
Total assets less total liabilities | ||||
| Equity | ||||
Share capital | 26 | |||
Share premium | ||||
Own shares held | 26 | ( | ( | ( |
Currency translation reserve | 26 | ( | ||
Cashflowhedgingreserve | 26 | |||
Retained earnings | ||||
Other reserve | 26 | |||
Equity attributable to the shareholders of the parent company | ||||
Non-controlling interest | 26 | ( | ( | ( |
Total equity |
| Own | Currency | Cash flow | Non- | ||||||
| Share | Share | shares | translation | hedging | Retained | Other | controlling | ||
| capital | premium | held | reserve | reserve | earnings | reserve | interest | Total | |
| Year ended 30 June 2024 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
Balance at 1 July 2023 | ( | ( | |||||||
Prioryearrestatement | ( | ( | |||||||
| Balanceat1July2023(restated) | ( | ( | |||||||
Profitfortheyear | |||||||||
| Other comprehensive income andexpense | |||||||||
| (net of tax) | |||||||||
| Remeasurementofdefinedbenefitpension | |||||||||
schemeassets/liabilities/reimbursementright | ( | ( | |||||||
Foreignexchangetranslationdifferences | ( | ( | |||||||
Foreignexchangerelatedtojointventure | ( | ( | |||||||
Changesinfairvalueofcashflowhedges | |||||||||
| Total other comprehensive income | |||||||||
and expense | ( | ( | ( | ||||||
| Total comprehensive income | |||||||||
and expense | ( | ||||||||
Share-based payments charge | |||||||||
Dividends paid | ( | ( | |||||||
Balance at 30 June 2024 | ( | ( | |||||||
| Year ended 30 June 2025 | |||||||||
Profitfortheyear | |||||||||
| Other comprehensive income andexpense | |||||||||
| (net of tax) | |||||||||
| Remeasurementofdefinedbenefitpension | |||||||||
schemeassets/liabilities/reimbursementright | |||||||||
Foreignexchangetranslationdifferences | ( | ( | |||||||
Foreignexchangerelatedtojointventure | |||||||||
Changesinfairvalueofcashflowhedges | |||||||||
| Total other comprehensive income | |||||||||
andexpense | ( | ||||||||
| Total comprehensive income | |||||||||
and expense | ( | ||||||||
Share-based payments charge | |||||||||
Distribution of own shares | ( | ||||||||
Purchaseofownshares | ( | ( | |||||||
Dividends paid | ( | ( | |||||||
Balance at 30 June 2025 | ( | ( | ( |
| 2025 | 2024 | ||
| notes | £’000 | £’000 | |
| Cash flows from operating activities | |||
Profitfortheyear | |||
| Adjustmentsfor: | |||
| Depreciationandimpairmentofproperty,plantandequipment,right-of-useassets, | |||
| andinvestmentproperties | 9,10,11 | ||
| Profitonsaleofproperty,plantandequipment | 9 | ( | ( |
| Amortisation and impairment of intangible assets | 12 | ||
| Shareofprofitsfromjointventures | 13 | ( | ( |
| Definedbenefitpensionschemespastserviceandadministrativecosts | 23 | ||
| Financial income | 5 | ( | ( |
| Financial expenses | 5 | ||
Share-based payment expense | 24 | ||
| Tax expense | 7 | ||
| Decrease/(increase)ininventories | |||
| Increaseintrade,financeleaseandotherreceivables | ( | ( | |
| Increase/(decrease)intradeandotherpayables | |||
| Increase/(decrease)inprovisions | |||
| Definedbenefitpensionschemecontributions | 23 | ( | ( |
| Income taxes paid | ( | ( | |
| Cash flows from operating activities | |||
| Investing activities | |||
| Purchaseofproperty,plantandequipment,andinvestmentproperties | 9,11 | ( | ( |
| Saleofproperty,plantandequipment | |||
| Development costs capitalised | 12 | ( | ( |
| Purchaseofotherintangibles | 12 | ( | ( |
| (Increase)/decreaseinbankdeposits | 15 | ( | |
| Interest received | 5 | ||
| Dividendsreceivedfromjointventures | 13 | ||
| Cash flows from investing activities | ( | ( | |
| Financing activities | |||
| Repayment of borrowings | 20 | ( | ( |
| Amountsreceivedasdepositfromjointventure | 13 | ||
| Interest paid | 5 | ( | ( |
| Repayment of principal of lease liabilities | 22 | ( | ( |
| Own shares purchased | 26 | ( | |
| Dividends paid | 26 | ( | ( |
| Cash flows from financing activities | ( | ( | |
| Net decrease in cash and cash equivalents | ( | ||
| Cash and cash equivalents at the beginning of the year | |||
| Effectofexchangeratefluctuationsoncashheld | |||
| Cash and cash equivalents at the end of the year | 15 |
2024 | 2023 | |||||
| Reported | Adjustment | Restated | Reported | Adjustment | Restated | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
| Assets | ||||||
Reimbursement right | – | 12,116 | 12,116 | – | 11,348 | 11,348 |
Deferred tax assets | 17,690 | 2,677 | 20,367 | 19,944 | 2,651 | 22,595 |
| Non-current liabilities | ||||||
Employee benefits | – | (21,349) | (21,349) | (45) | (20,493) | (20,538) |
| Equity | ||||||
Retained earnings | 876,990 | (6,556) | 870,434 | 871,777 | (6,494) | 865,283 |
Item | Key judgements (J) and estimates (E) | Page |
Taxation | J – Whether uncertain tax positions need to be recognised | 132 |
Research and development costs | J – Whether a project meets the criteria for capitalisation | 138 |
Goodwill and capitalised development costs | E – Estimates of future cash flows for impairment testing | 138 |
Inventories | E – Determination of net realisable value | 143 |
Defined benefit pension schemes | E – Valuation of defined benefit pension schemes’ liabilities | 146 |
Defined benefit pension schemes | J – Whether past service costs need to be recognised | 146 |
Cash flow hedges | E – Estimates of highly probable forecasts of the hedged item | 151 |
Adjusted performance measures | J – Whether items are appropriate to exclude from adjusted measures | 159 |
Employment benefits | J – When termination benefits should be recognised | 162 |
| Manufacturing | Analytical instruments | |||
| technologies | and medical devices | Total | ||
| Year ended 30 June 2025 | £’000 | £’000 | £’000 | |
Revenue | 671,469 | 41,575 | 713,044 | |
Depreciation, amortisation and impairment | 33,001 | 2,745 | 35,746 | |
Research and development expenditure | 65,727 | 3,18 | 3 | 68,910 |
Operating profit | 107,5 9 3 | 292 | 107,885 | |
Share of profits of joint ventures | 3,538 | – | 3,538 | |
Net financial income | – | – | 6,577 | |
Profit before tax | – | – | 118,000 |
| Manufacturing | Analytical instruments | ||
| technologies | and medical devices | Total | |
| Year ended 30 June 2024 | £’000 | £’000 | £’000 |
Revenue | 648,063 | 43,238 | 691,301 |
Depreciation, amortisation and impairment | 31,374 | 1,454 | 32,828 |
Research and development expenditure | 68,205 | 2,855 | 71,060 |
Operating profit | 103,181 | 5,486 | 108,667 |
Share of profits of joint ventures | 3,880 | – | 3,880 |
Net financial income | – | – | 10,047 |
Profit before tax | – | – | 122,594 |
| 2025 | 2024 | ||
| £’000 | £’000 | ||
UK | 286,145 | 268,0 | 27 |
Overseas | 166,118 | 16 | 6,816 |
Total non-current assets | 452,263 | 434 | ,843 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Goods, capital equipment and installation | 642,378 | 624,491 |
Aftermarket services | 70,666 | 66,810 |
Total Group revenue | 713,044 | 691,301 |
| 2025 | 2024 | ||
| £’000 | £’000 | ||
APAC total | 337,721 | 318,83 | 6 |
34,017 | 37,9 56 | ||
EMEA, excluding UK | 173,751 | 1 | 70,077 |
EMEA total | 207,768 | 208,033 | |
Americas total | 167,555 | 164,432 | |
Total Group revenue | 713,044 | 691,301 | |
| 2025 | 2024 | ||
| £’000 | £’000 | ||
China | 186,495 | 17 7,155 | |
USA | 142,860 | 138,8 | 36 |
Germany | 55,682 | 5 | 4,572 |
Japan | 49,273 | 4 | 9,329 |
| 2025 | 2024 | |||
| £’000 | £’000 | |||
Wages and salaries | 247,070 | 2 | 33,536 | |
Compulsory social security contributions | 30,514 | 27,13 | 0 | |
Contributions to defined contribution pension schemes | 29,269 | 27,851 | ||
Share-based payment charge | 790 | 883 | ||
Total payroll costs | 307,643 | 28 | 9,400 |
| 2025 | 2024 | |
| Number | Number | |
UK | 3,491 | 3,400 |
Overseas | 1,848 | 1,813 |
Average number of employees | 5,339 | 5,213 |
| 2025 | 2024 | ||
| £’000 | £’000 | ||
Short-term employee benefits | 6,322 | 6 | ,13 9 |
Post-employment benefits | 489 | 529 | |
Share-based payment charge | 790 | 883 | |
Total remuneration of key management personnel | 7,601 | 7,5 51 | |
| Adjusted | Adjusting | Statutory | Adjusted | Adjusting | Statutory | ||
| total | items | total | total | items | total | ||
| 2025 | 2025 | 2025 | 2024 | 2024 | 2024 | ||
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | ||
Production costs | 272,814 | – | 272,814 | 269,562 | – | 269,562 | |
Research and development expenditure | 68,910 | – | 68,910 | 71,060 | – | 71,060 | |
Other engineering expenditure | 46,770 | 4,379 | 51,149 | 35,723 | – | 35,723 | |
Gross engineering expenditure | 115,680 | 4,379 | 120,059 | 106,783 | – | 106,783 | |
Development expenditure capitalised (netofamortisation) | (5,574) | – | (5,574) | (4,287) | – | (4,287) | |
Development expenditure impaired | 1,818 | – | 1,818 | 3,299 | – | 3,299 | |
Research and development tax credit | (5,088) | – | (5,088) | (7,6 9 9) | – | (7,6 99) | |
Total engineering costs | 106,836 | 4,379 | 111,215 | 98,096 | – | 98,096 | |
Total cost of sales | 379,650 | 4,379 | 384,029 | 367,6 58 | – | 3 67,65 | 8 |
| 2025 | 2024 | |
| Financial income | £’000 | £’000 |
Bank interest receivable | 11,741 | 9,110 |
Fair value gains from one-month forward currency contracts | 3,360 | 318 |
Interest on pension schemes’ assets | 503 | 2,908 |
Other interest income | 913 | – |
Total financial income | 16,517 | 12,336 |
| 2025 | 2024 | |
| Financial expenses | £’000 | £’000 |
Currency losses | 3,899 | 1,645 |
Lease interest | 685 | 537 |
Interest payable on amounts owed to joint ventures | 371 | 55 |
Interest payable on borrowings | 49 | 36 |
Other interest payable | 4,936 | 16 |
Total financial expenses | 9,940 | 2,289 |
| 2025 | 2024 | |||
| notes | £’000 | £’000 | ||
| Depreciation and impairment of property, plant and equipment, right-of-use assets, | ||||
and investment properties | 9,10,11 | 29,057 | 24,19 | 5 |
Profit on sale of property, plant and equipment | 9 | (1,083) | (1,199) | |
Amortisation and impairment of intangible assets | 12 | 6,689 | 8,633 | |
Grant income | – | (3,280) | (2,816) |
| 2025 | 2024 | ||
| £’000 | £’000 | ||
| Current tax: | |||
UK corporation tax on profits for the year | 7,5 50 | 3,748 | |
UK corporation tax – prior year adjustments | 2,778 | (693) | |
Overseas tax on profits for the year | 16,018 | 14,497 | |
Overseas tax – prior year adjustments | 6,166 | 105 | |
Global minimum tax | 757 | – | |
Total current tax | 33,269 | 17,657 | |
| Deferred tax: | |||
Origination and reversal of temporary differences | 2,077 | 8,613 | |
Prior year adjustments | (1,203) | (473) | |
Derecognition of previously recognised tax losses and excess interest | 323 | 427 | |
Recognition of previously unrecognised tax losses and excess interest | (223) | (519) | |
974 | 8,048 | ||
Tax charge on profit | 34,243 | 25, | 705 |
| 2025 | 2024 | ||
| £’000 | £’000 | ||
Profit before tax | 118,000 | 122,594 | |
Tax at 25.0% (2024:25.0%) | 29,500 | 3 | 0,649 |
| Effects of: | |||
Different tax rates applicable in overseas subsidiaries | (4,648) | (4,866) | |
Permanent differences | 1,439 | 1,028 | |
Global minimum tax | 757 | – | |
Companies with unrelieved tax losses | 7 | 93 | |
Share of profits of joint ventures | (885) | (970) | |
Tax incentives | (123) | – | |
Prior year adjustments | 7,741 | (1,061) | |
Recognition of previously unrecognised tax losses and excess interest | (223) | (519) | |
Derecognition of previously recognised tax losses and excess interest | 323 | 427 | |
Irrecoverable withholding tax | 720 | 447 | |
Deferred tax on unremitted earnings | (425) | 425 | |
Other differences | 60 | 52 | |
Tax charge on profit | 34,243 | 25, | 705 |
Effective tax rate | 29.0% | 21.0% | |
2025 | 2024 | |||||
| Assets | Liabilities | Net | Assets | Liabilities | Net | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Property, plant and equipment | 574 | (33,086) | (32,512) | 549 | (29,946) | (29,397) |
Intangible assets | – | (4,655) | (4,655) | – | (4,067) | (4,067) |
Intragroup trading (inventories) | 16,262 | – | 16,262 | 15,147 | – | 15,147 |
Intragroup trading (fixed assets) | 1,129 | – | 1,129 | 1,101 | – | 1,101 |
Defined benefit pension schemes | 6,128 | (2,380) | 3,748 | 6,191 | (2,445) | 3,746 |
Reimbursement right | – | (3,744) | (3,744) | – | (3,514) | (3,514) |
Derivatives | – | (5,088) | (5,088) | – | (3,637) | (3,637) |
Tax losses | 1,545 | – | 1,545 | 1,823 | – | 1,823 |
Other | 7,663 | (700) | 6,963 | 6,895 | (1,330) | 5,565 |
Balance at the end of the year | 33,301 | (49,653) | (16,352) | 31,706 | (44,939) | (13,233) |
| 2025 | 2024 | |
| £’000 | £’000 | |
Balance at the beginning of the year | (13,233) | (16,175) |
Movements in relation to property, plant and equipment | (3,115) | (5,008) |
Movements in relation to intangible assets | (588) | (145) |
Movements in relation to intragroup trading (inventories) | 1,115 | (1,618) |
Movements in relation to intragroup trading (fixed assets) | 28 | (669) |
Movements in relation to defined benefit pension schemes | 146 | (521) |
Movements in relation to tax losses | (278) | (458) |
Movements in relation to other | 1,718 | 371 |
Movements in the Consolidated income statement | (974) | (8,048) |
Movements in relation to the cash flow hedging reserve | (1,451) | (1,453) |
Movements in relation to the defined benefit pension scheme assets/liabilities/reimbursement right | (374) | 12,450 |
Movements in the Consolidated statement of comprehensive income and expense | (1,825) | 10,997 |
Currency adjustment | (320) | (7) |
Balance at the end of the year | (16,352) | (13,233) |
| Freehold | Assets in the | |||||
| land and | Plant and | Motor | course of | |||
| buildings | equipment | vehicles | construction | Total | ||
| Year ended 30 June 2025 | £’000 | £’000 | £’000 | £’000 | £’000 | |
| Cost | ||||||
At 1 July 2024 | 255,536 | 278,189 | 6,099 | 56,593 | 596,417 | |
Additions | 6,374 | 23,258 | 1,220 | 15,421 | 46,273 | |
Transfers | 19,032 | 18,443 | – | (37,475) | – | |
Transfers to Investment properties | (2,795) | (597) | – | – | (3,392) | |
Disposals | (725) | (7,819) | (1,206) | – | (9,750) | |
Currency adjustment | (2,794) | (2,420) | (151) | – | (5,365) | |
At 30 June 2025 | 274,628 | 309,054 | 5,962 | 34,539 | 624,183 | |
| Depreciation | ||||||
At 1 July 2024 | 49,460 | 216,838 | 5,079 | – | 271,377 | |
Charge for the year | 5,275 | 17,4 97 | 470 | – | 23,242 | |
Impairment | 989 | – | – | – | 989 | |
Transfers to Investment properties | (1,179) | (439) | – | – | (1,618) | |
Disposals | (270) | (4,619) | (1,057) | – | (5,946) | |
Currency adjustment | (485) | (1,562) | (101) | – | (2,148) | |
At 30 June 2025 | 53,790 | 2 | 27,715 | 4,391 | – | 285,896 |
| Net book value | ||||||
At 30 June 2025 | 220,838 | 81,339 | 1,571 | 34,539 | 338,287 | |
At 30 June 2024 | 206,076 | 61,351 | 1,020 | 56,593 | 325,040 |
| Freehold | Assets in the | |||||
| land and | Plant and | Motor | course of | |||
| buildings | equipment | vehicles | construction | Total | ||
| Year ended 30 June 2024 | £’000 | £’000 | £’000 | £’000 | £’000 | |
| Cost | ||||||
At 1 July 2023 | 213,385 | 273,156 | 7,112 | 53,469 | 5 4 | 7,122 |
Reclassification | 3,669 | (3,669) | – | – | – | |
Additions | 2,412 | 10,615 | 308 | 51,912 | 65,247 | |
Transfers | 42,637 | 6,151 | – | (48,788) | – | |
Disposals | (2,916) | (6,810) | (1,245) | – | (10,971) | |
Currency adjustment | (3,651) | (1,254) | (76) | – | (4,981) | |
At 30 June 2024 | 255,536 | 278,189 | 6,099 | 56,593 | 596,417 | |
| Depreciation | ||||||
At 1 July 2023 | 45,647 | 209,546 | 5,844 | – | 261,037 | |
Reclassification | 540 | (540) | – | – | – | |
Charge for the year | 4,378 | 14,526 | 382 | – | 19,286 | |
Disposals | (658) | (5,951) | (1,086) | – | (7,695) | |
Currency adjustment | (447) | (743) | (61) | – | (1,251) | |
At 30 June 2024 | 49,460 | 216,838 | 5,079 | – | 271,377 | |
| Net book value | ||||||
At 30 June 2024 | 206,076 | 61,351 | 1,020 | 56,593 | 325,040 | |
At 30 June 2023 | 167,738 | 63,610 | 1,268 | 53,469 | 286,085 |
| Leasehold | Plant and | Motor | ||
| property | equipment | vehicles | Total | |
| Year ended 30 June 2025 | £’000 | £’000 | £’000 | £’000 |
| Net book value | ||||
At 1 July 2024 | 9,899 | 66 | 4,781 | 14,746 |
Additions | 1,746 | 49 | 841 | 2,636 |
Reductions | – | – | (12) | (12) |
Depreciation | (2,541) | (43) | (2,049) | (4,633) |
Currency adjustment | (451) | 2 | (70) | (519) |
At 30 June 2025 | 8,653 | 74 | 3,491 | 12,218 |
| Leasehold | Plant and | Motor | |||
| property | equipment | vehicles | Total | ||
| Year ended 30 June 2024 | £’000 | £’000 | £’000 | £’000 | |
| Net book value | |||||
At 1 July 2023 | 5,069 | 89 | 3,244 | 8,402 | |
Additions | 7,32 | 0 | 51 | 3,843 | 11,214 |
Reductions | – | – | (3) | (3) | |
Depreciation | (2,434) | (73) | (2,146) | (4,653) | |
Currency adjustment | (56) | (1) | (157) | (214) | |
At 30 June 2024 | 9,899 | 66 | 4,781 | 14,746 |
| 2025 | 2024 | |
| £’000 | £’000 | |
| Cost | ||
Balance at the beginning of the year | 12,103 | 11,896 |
Additions | – | 271 |
Transfers from Property, plant & equipment | 3,392 | – |
Currency adjustment | (284) | (64) |
Balance at the end of the year | 15,211 | 12,103 |
| Depreciation | ||
Balance at the beginning of the year | 1,818 | 1,573 |
Charge for the year | 193 | 256 |
Transfers from Property, plant & equipment | 1,618 | – |
Currency adjustment | 16 | (11) |
Balance at the end of the year | 3,645 | 1,818 |
Net book value | 11,566 | 10,285 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Rental income | 945 | 829 |
Direct operating expenses (includingrepairsandmaintenance) | 218 | 247 |
Profit | 727 | 582 |
| Internally | Intellectual | ||||
| generated | property and | ||||
| development | Software | other intangible | |||
| Goodwill | costs | licences | assets | Total | |
| Year ended 30 June 2025 | £’000 | £’000 | £’000 | £’000 | £’000 |
| Cost | |||||
At 1 July 2024 | 20,258 | 187,941 | 12,197 | 4,864 | 225,260 |
Additions | – | 9,999 | 286 | – | 10,285 |
Disposals | – | (8,368) | – | – | (8,368) |
Currency adjustment | (376) | – | 22 | 15 | (339) |
At 30 June 2025 | 19,882 | 189,572 | 12,505 | 4,879 | 226,838 |
| Amortisation | |||||
At 1 July 2024 | 9,028 | 154,531 | 11,751 | 2,607 | 177,917 |
Charge for the year | – | 4,426 | 191 | 254 | 4,871 |
Impairment | – | 1,818 | – | – | 1,818 |
Disposals | – | (8,368) | – | – | (8,368) |
Currency adjustment | – | – | 14 | 36 | 50 |
At 30 June 2025 | 9,028 | 152,407 | 11,956 | 2,897 | 176,288 |
| Net book value | |||||
At 30 June 2025 | 10,854 | 37,165 | 549 | 1,982 | 50,550 |
At 30 June 2024 | 11,230 | 33,410 | 446 | 2,257 | 47,3 43 |
| Internally | Intellectual | ||||
| generated | property and other | ||||
| development | Software | intangible | |||
| Goodwill | costs | licences | assets | Total | |
| Year ended 30 June 2024 | £’000 | £’000 | £’000 | £’000 | £’000 |
| Cost | |||||
At 1 July 2023 | 20,261 | 178,660 | 11,978 | 4,875 | 215,774 |
Additions | – | 9,281 | 246 | – | 9,527 |
Currency adjustment | (3) | – | (27) | (11) | (41) |
At 30 June 2024 | 20,258 | 187,9 41 | 12,197 | 4,864 | 225,260 |
| Amortisation | |||||
At 1 July 2023 | 9,028 | 146,221 | 11,605 | 2,452 | 169,306 |
Charge for the year | – | 5,011 | 165 | 158 | 5,334 |
Impairment | – | 3,299 | – | – | 3,299 |
Currency adjustment | – | – | (19) | (3) | (22) |
At 30 June 2024 | 9,028 | 154,531 | 11,751 | 2,607 | 177,917 |
| Net book value | |||||
At 30 June 2024 | 11,230 | 33,410 | 446 | 2,257 | 47,3 43 |
At 30 June 2023 | 11,233 | 32,439 | 373 | 2,423 | 46,468 |
| 2025 | 2024 | |
| £’000 | £’000 | |
itp GmbH | 2,959 | 2,934 |
Renishaw Mayfield S.A. | 2,180 | 2,089 |
Renishaw Fixturing Solutions, LLC | 5,055 | 5,497 |
Other smaller acquisitions | 660 | 710 |
Total goodwill | 10,854 | 11,230 |
| 2025 | 2024 | ||
Business acquired | CGU | Discount rate | Discount rate |
itp GmbH | itp GmbH entity (‘ITP’) | 15.1% | 13.6% |
Renishaw Fixturing Solutions, LLC | Renishaw plc (‘PLC’) | 16.5% | 14.6% |
Renishaw Mayfield S.A. | Renishaw Mayfield S.A. entity (‘Mayfield’) | 20.5% | 24.6% |
| Country of incorporation and | 2025 | 2024 | |
| principal place of business | Ownership % | Ownership % | |
RLS Merilna tehnika d.o.o. (‘RLS’)–jointventure | Slovenia | 50.0 | 50.0 |
Metrology Software Products Limited (‘MSP’)–joint venture | England & Wales | 70.0 | 70.0 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Balance at the beginning of the year | 25,485 | 22,414 |
Dividends received | (1,500) | (498) |
Share of profits of joint ventures | 3,538 | 3,880 |
Currency adjustment | 169 | (311) |
Balance at the end of the year | 27,692 | 25,485 |
RLS | MSP | |||
| 2025 | 2024 | 2025 | 2024 | |
| £’000 | £’000 | £’000 | £’000 | |
Assets | 52,093 | 49,295 | 6,258 | 5,470 |
Liabilities | (5,526) | (6,167) | (532) | (442) |
Net assets | 46,567 | 43,128 | 5,726 | 5,028 |
Group’s share of net assets | 23,284 | 21,564 | 4,008 | 3,520 |
Revenue | 38,045 | 38,548 | 3,389 | 2,947 |
Profit for the year | 6,100 | 6,546 | 697 | 867 |
Group’s share of profit for the year | 3,050 | 3,273 | 488 | 607 |
2025 | 2024 | |||||||
| Gross | Net | Gross | Net | |||||
| investment | Interest | investment | investment | Interest | investment | |||
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |||
Receivable in less than one year | 6,027 | 832 | 5,195 | 4,761 | 900 | 3,861 | ||
Receivable between one and two years | 5,416 | 572 | 4,844 | 5,903 | 765 | 5,138 | ||
Receivable between two and three years | 4,120 | 317 | 3,803 | 4,038 | 347 | 3,691 | ||
Receivable between three and four years | 2,669 | 154 | 2,515 | 2,072 | 138 | 1,934 | ||
Receivable between four and five years | 803 | 15 | 788 | 1,264 | 83 | 1,181 | ||
Total future minimum lease payments receivable | 19,035 | 1,890 | 17,145 | 18, | 038 | 2,233 | 15,80 | 5 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Receivable in less than one year | 1,138 | 1,042 |
Receivable in more than one year | 1,323 | 707 |
Total future minimum lease payments receivable | 2,461 | 1,749 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Bank balances and cash in hand | 87,138 | 75,090 |
Short-term deposits | 282 | 47,203 |
Balance at the end of the year | 87,420 | 122,293 |
| 2025 | 2024 | ||
| £’000 | £’000 | ||
Raw materials | 56,911 | 53,54 | 2 |
Work in progress | 31,623 | 32, | 840 |
Finished goods | 70,931 | 75,54 | 6 |
Balance at the end of the year | 159,465 | 16 | 1,928 |
Warranty | Other | |||
| 2025 | 2024 | 2025 | 2024 | |
| £’000 | £’000 | £’000 | £’000 | |
Balance at the beginning of the year | 2,997 | 2,758 | – | – |
Created during the year | 3,281 | 2,633 | 6,152 | – |
Unused amounts reversed | (924) | – | – | – |
Utilised in the year | (2,528) | (2,394) | – | – |
(171) | 239 | 6,152 | – | |
Balance at the end of the year | 2,826 | 2,997 | 6,152 | – |
| 2025 | 2024 | ||
| £’000 | £’000 | ||
Goods, capital equipment and installation | 813 | 210 | |
Aftermarket services | 8,251 | 6,955 | |
Deferred revenue | 9,064 | 7,16 | 5 |
Advances received from customers | 5,605 | 3,715 | |
Balance at the end of the year | 14,669 | 10,880 |
| 2025 | 2024 | ||
| £’000 | £’000 | ||
Payroll taxes and social security | 7,484 | 6,477 | |
Performance bonuses | 11,047 | 9,990 | |
Holiday pay and retirement accruals | 11,091 | 9,397 | |
Indirect tax payable | 5,278 | 5,163 | |
Deferred research and development tax credit (‘RDEC’) | 1,131 | – | |
Other creditors and accruals | 21,101 | 19,317 | |
Total other payables | 57,132 | 5 | 0,344 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Balance at the beginning of the year | 3,522 | 4,694 |
Interest | 49 | 36 |
Repayments | (794) | (799) |
Currency adjustment | 107 | (409) |
Balance at the end of the year | 2,884 | 3,522 |
| Leasehold | Plant and | Motor | ||
| property | equipment | vehicles | Total | |
| 2025 | £’000 | £’000 | £’000 | £’000 |
Due in less than one year | 2,490 | 34 | 1,985 | 4,509 |
Due between one and two years | 2,110 | 18 | 1,303 | 3,431 |
Due between two and three years | 1,667 | 12 | 501 | 2,180 |
Due between three and four years | 1,135 | 11 | 80 | 1,226 |
Due between four and five years | 182 | 4 | 2 | 188 |
Due in more than five years | 4,358 | – | – | 4,358 |
Total future minimum lease payments payable | 11,942 | 79 | 3,871 | 15,892 |
Effect of discounting | (2,916) | (4) | (211) | (3,131) |
Lease liabilities | 9,026 | 75 | 3,660 | 12,761 |
| Leasehold | Plant and | Motor | ||
| property | equipment | vehicles | Total | |
| 2024 | £’000 | £’000 | £’000 | £’000 |
Due in less than one year | 2,396 | 36 | 2,161 | 4,593 |
Due between one and two years | 2,137 | 22 | 1,816 | 3,975 |
Due between two and three years | 1,862 | 7 | 1,035 | 2,904 |
Due between three and four years | 1,549 | 1 | 205 | 1,755 |
Due between four and five years | 1,001 | – | 8 | 1,009 |
Due in more than five years | 4,454 | – | – | 4,454 |
Total future minimum lease payments payable | 13,399 | 66 | 5,225 | 18,690 |
Effect of discounting | (3,311) | (2) | (355) | (3,668) |
Lease liabilities | 10,088 | 64 | 4,870 | 15,022 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Depreciation of right-of-use assets | 4,633 | 4,653 |
Interest expense on lease liabilities | 685 | 537 |
Expenses relating to short-term and low-value leases | 395 | 138 |
Total expense recognised in the Consolidated income statement | 5,713 | 5,328 |
Total cash outflows for leases | 5,364 | 5,034 |
1 July 2024 | Cash flows | Other | Currency | 30 June 2025 | |
Lease liabilities | 15,022 | (4,284) | 2,564 | (541) | 12,761 |
Borrowings | 3,522 | (794) | 49 | 107 | 2,884 |
18,544 | (5,078) | 2,612 | (434) | 15,644 |
1 July 2023 | Cash flows | Other | Currency | 30 June 2024 | ||
Lease liabilities | 8,633 | (4,359) | 10,9 | 67 | (219) | 15,022 |
Borrowings | 4,694 | (799) | 36 | (409) | 3,522 | |
13,327 | (5,158) | 11,003 | (628) | 18,544 |
30 June 2025 | 30 June 2024 | |||||
UK scheme | Ireland scheme | Germany scheme | UK scheme | Ireland scheme | Germany scheme | |
Discount rate | 5.55% | 4.00% | 3.90% | 5.10% | 3.75% | 3.70% |
Rate of increase in pension payments | 2.85% | 2.25% | 2.00% | 2.95% | 2.50% | 2.00% |
Rate of increase in salary | n/a | n/a | 2.50% | n/a | n/a | 2.50% |
Inflation rate (RPI) | 3.05% | 2.25% | n/a | 3.25% | 2.50% | n/a |
2.05% 1 | 2.25% 1 | |||||
| Inflation rate (CPI) | 3.05% 2 | 2.25% | 2.00% | 3.25% 2 | 2.50% | 2.00% |
Retirement age | 65 | 65 | 67 | 64 | 65 | 67 |
| 2025 | 2024 | |
| years | years | |
Male currently aged 65 | 21.1 | 21.1 |
Female currently aged 65 | 23.5 | 23.5 |
Male currently aged 45 | 21.8 | 21.8 |
Female currently aged 45 | 24.4 | 24.4 |
| 30 June | % of | 30 June | % of | |
| 2025 | total | 2024 | total | |
| £’000 | assets | £’000 | assets | |
| Market value of assets: | ||||
Insurance contract | 118,158 | 83 | 129,207 | 84 |
Credit and fixed income funds | 7,924 | 6 | 9,268 | 6 |
Index linked gilts | 5,815 | 4 | 1,269 | 1 |
Multi-asset funds | 4,640 | 3 | 5,869 | 4 |
Equities | 4,295 | 3 | 6,861 | 4 |
Cash and other | 781 | 1 | 660 | – |
141,613 | 100 | 153,134 | 100 | |
Actuarial value of liabilities | (151,301) | (163,638) | – | |
Deficit in the schemes | (9,688) | (10,504) | – | |
Deferred tax thereon | 3,748 | 3,746 | – |
| Reimbursement | ||||
| right | Assets | Liabilities | Total | |
| Year ended 30 June 2025 | £’000 | £’000 | £’000 | £’000 |
Balance at the beginning of the year | 12,116 | 153,134 | (163,638) | 1,612 |
Contributions paid | – | 162 | – | 162 |
Interest on pension schemes | – | 7,465 | (6,962) | 503 |
Remeasurement gain/(loss) under IAS 19 | 1,498 | (12,267) | 13,546 | 2,777 |
Scheme administration expenses | (705) | (1,128) | – | (1,833) |
Benefits paid | – | (5,753) | 5,753 | – |
Balance at the end of the year | 12,909 | 141,613 | (151,301) | 3,221 |
| Reimbursement | ||||
| right | Assets | Liabilities | Total | |
| Year ended 30 June 2024 | £000 | £’000 | £’000 | £’000 |
Balance at the beginning of the year | 11,348 | 196,329 | (159,451) | 48,226 |
Contributions paid | – | 161 | – | 161 |
Interest on pension schemes | – | 9,581 | (6,673) | 2,908 |
Remeasurement gain/(loss) under IAS 19 | 768 | (45,054) | (4,490) | (48,776) |
Scheme administration expenses | – | (907) | – | (907) |
Benefits paid | – | (6,976) | 6,976 | – |
Balance at the end of the year | 12,116 | 153,134 | (163,638) | 1,612 |
| 2025 | 2024 | |
| £’000 | £’000 | |
| Actuarial gain/(loss) arising from: | ||
Changes in demographic assumptions | – | 35 |
Changes in financial assumptions | 14,857 | 775 |
Experience adjustment | 187 | (4,532) |
Return on plan assets excluding interest income | (12,267) | (45,054) |
Total amount recognised in the Consolidated statement of comprehensive income and expense | 2,777 | (48,776) |
Variation | Approximate effect on liabilities | |
UK – discount rate | Increase/decrease by 0.5% | -£10.2m/+£11.4m |
UK – future inflation | Increase/decrease by 0.5% | +£7.7m/-£7.8 m |
UK – mortality | Increased/decreased life by one year | +£5.7m/-£4.5m |
| Trade and finance | Cash and cash equivalents | ||||||||
lease receivables | Other receivables | and bank deposits | |||||||
| 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | ||||
| Currency | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |||
Pound Sterling | 17,076 | 17,258 | 30,438 | 24,807 | 223,491 | 168,781 | |||
US Dollar | 50,034 | 57,209 | 970 | 1,613 | 11,322 | 8,261 | |||
Euro | 30,669 | 3 | 0,699 | 3,525 | 2,320 | 5,153 | 10 | ,532 | |
Chinese Yuan | 13,592 | 11,179 | 512 | 574 | 17,0 69 | 11,284 | |||
Japanese Yen | 13,181 | 13,135 | 136 | 144 | 2,730 | 3,358 | |||
Other | 21,057 | 20,398 | 5,151 | 4,618 | 13,881 | 15 | ,619 | ||
145,609 | 14 | 9,878 | 40,732 | 3 | 4,076 | 273,646 | 217,835 | ||
| 2025 | 2024 | ||
| £’000 | £’000 | ||
Past due zero to one month | 13,601 | 13,25 | 0 |
Past due one to two months | 5,935 | 7,76 | 3 |
Past due more than two months | 8,538 | 13,041 | |
Balance at the end of the year | 28,074 | 4,054 | 3 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Balance at the beginning of the year | 4,479 | 3,438 |
Changes in amounts provided | 3,215 | 2,264 |
Amounts used | (1,800) | (1,223) |
Balance at the end of the year | 5,894 | 4,479 |
| Risk category 1 | Risk category 2 | Risk category 3 | Risk category 4 | Risk category 5 | 2025 | Total | |
| Year ended 30 June 2025 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Gross trade receivables | 14,397 | 31,663 | 82,780 | 5,518 | – | 134,358 | |
Expected credit loss rate | 0.55% | 0.61% | 0.66% | 0.71% | – | 0.52% | |
Expected credit loss allowance | 80 | 192 | 531 | 39 | – | 842 | |
Specific loss allowance | – | – | 4,730 | 322 | – | 5,052 | |
Total loss allowance | 80 | 192 | 5,261 | 361 | – | 5,894 | |
Net trade receivables | 14,317 | 31,471 | 7 7,519 | 5,157 | – | 128,464 |
| Risk category 1 | Risk category 2 | Risk category 3 | Risk category 4 | Risk category 5 | 2024 | Total | |
| Year ended 30 June 2024 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Gross trade receivables | 14,215 | 38,781 | 84,049 | 1,508 | – | 138,553 | |
Expected credit loss rate | 0.46% | 0.50% | 0.54% | 0.58% | – | 0.52% | |
Expected credit loss allowance | 65 | 193 | 447 | 9 | – | 714 | |
Specific loss allowance | – | 4 | 3,440 | 322 | – | 3,766 | |
Total loss allowance | 65 | 197 | 3,887 | 331 | – | 4,480 | |
Net trade receivables | 14,150 | 38,584 | 8 0,162 | 1,177 | – | 134,073 |
| 2025 | 2024 | ||
| £’000 | £’000 | ||
Indirect tax receivable | 10,959 | 7,206 | |
Software maintenance | 10,181 | 7,816 | |
Grants | 885 | 875 | |
Research and development tax credit (‘RDEC’)recoverable | 1,224 | 4,969 | |
Contract assets | 1,509 | 309 | |
Other prepayments | 15,974 | 12,901 | |
Total other receivables | 40,732 | 3 | 4,076 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Receivable between one and two years | 7,878 | 1,387 |
Receivable between two and five years | – | – |
7,878 | 1,387 |
| Contractual cash flows | ||||||
| Carrying | Effect of | Gross | ||||
| amount | discounting | maturities | Up to 1 year | 1-2 years | 3-5 years | |
| Year ended 30 June 2025 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
Trade payables | 25,943 | – | 25,943 | 25,943 | – | – |
Other payables | 57,132 | – | 57,132 | 57,132 | – | – |
Borrowings | 2,884 | 85 | 2,969 | 764 | 754 | 1,451 |
Forward exchange contracts | 1,246 | – | 1,246 | 150 | 1,096 | – |
87, 205 | 85 | 87,2 90 | 83,989 | 1,850 | 1,451 |
| Contractual cash flows | |||||||||
| Carrying | Effect of | Gross | |||||||
| amount | discounting | maturities | Up to 1 year | 1-2 years | 3-5 years | ||||
| Year ended 30 June 2024 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |||
Trade payables | 21, | 330 | – | 21,330 | 21,330 | – | – | ||
Other payables | 50, | 344 | – | 50 | ,344 | 50, | 344 | – | – |
Borrowings | 3,522 | 138 | 3,660 | 756 | 745 | 2,159 | |||
Forward exchange contracts | 625 | – | 625 | 448 | 177 | – | |||
75,821 | 138 | 75,959 | 72,878 | 922 | 2,159 |
2025 | 2024 | |||
| Nominal value | Fair value | Nominal value | Fair value | |
| £’000 | £’000 | £’000 | £’000 | |
US Dollar | 299,987 | 18,954 | 332,679 | 7,388 |
Euro | 146,500 | 613 | 173,089 | 4,661 |
Japanese Yen | 21,947 | 1,354 | 15,581 | 2,260 |
Canadian Dollar | 5,133 | 56 | – | – |
473,567 | 20,977 | 521,349 | 14,309 |
2025 | 2024 | |||||
| Average | Year end | Average | Average | Year end | Average | |
| forward | exchange | exchange | forward | exchange | exchange | |
| Currency | contract rate | rate | rate | contract rate | rate | rate |
US Dollar | 1.28 | 1.37 | 1.30 | 1.25 | 1.27 | 1.26 |
Euro | 1.14 | 1.17 | 1.19 | 1.13 | 1.18 | 1.17 |
Japanese Yen | 178 | 198 | 193 | 140 | 203 | 189 |
Canadian Dollar | 1.85 | 1.87 | 1.82 | – | – | – |
2025 | 2024 | |||
| Nominal value | Fair value | Nominal value | Fair value | |
| £’000 | £’000 | £’000 | £’000 | |
| Forward currency contracts in a designated cash flow hedge (i) | ||||
Non-current derivative assets | 137,417 | 7,878 | 14 0,109 | 1,387 |
Current derivative assets | 218,870 | 13,606 | 245,577 | 13,338 |
Current derivative liabilities | 19,339 | (37) | 790 | – |
Non-current derivative liabilities | 33,559 | (1,096) | 54,852 | (177) |
409,185 | 20,351 | 441,328 | 14,548 | |
Amounts recognised in the Consolidated statement of comprehensive income and expense | – | 5,804 | – | 5,812 |
| Forward currency contracts not in a designated cash flow hedge (ii) | ||||
Current derivative assets | 56,873 | 739 | 17,614 | 209 |
Current derivative liabilities | 7,5 09 | (113) | 62,407 | (448) |
64,382 | 626 | 80,021 | (239) | |
| Amounts recognised in Financial income/(expense) in the | ||||
Consolidated income statement | – | 3,360 | – | 318 |
| Total forward contracts and options | ||||
Non-current derivative assets | 137,417 | 7, 878 | 14 0,109 | 1,387 |
Current derivative assets | 275,743 | 14,345 | 26 3,191 | 13,547 |
Current derivative liabilities | 26,848 | (150) | 63,197 | (448) |
Non-current derivative liabilities | 33,559 | (1,096) | 54,852 | (177) |
473,567 | 20,977 | 521,349 | 14,309 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Allotted, called-up and fully paid 72,788,543 ordinary shares of 20p each | 14,558 | 14,558 |
| 2025 | 2024 | |
| £’000 | £’000 | |
FY2024 final dividend paid of 59.4p per share (2023: 59.4p) | 43,205 | 4 3,195 |
Interim dividend paid of 16.8p per share (2024: 16.8p) | 12,219 | 12,217 |
Total dividends paid | 55,424 | 55,412 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Balance at the beginning of the year | (2,963) | (2,963) |
Acquisition of own shares | (154) | – |
Disposal of own shares on vesting of awards | 977 | – |
Balance at the end of the year | (2,140) | (2,963) |
| 2025 | 2024 | |
| £’000 | £’000 | |
Balance at the beginning of the year | 1,380 | 497 |
Disposal of own shares on vesting of awards | (977) | – |
Share-based payments charge in respect of shares vesting in 2024 | 80 | 245 |
Share-based payments charge in respect of shares vesting in 2025 | 656 | 638 |
Share-based payments charge in respect of shares vesting in 2027 | 54 | – |
Balance at the end of the year | 1,193 | 1,380 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Balance at the beginning of the year | 2,480 | 6,772 |
Loss on net assets of foreign currency operations | (6,295) | (3,811) |
Loss on intragroup loans classified as net investments in foreign operations | – | (227) |
Tax on translation of net investments in foreign operations | – | 57 |
Loss in the year relating to subsidiaries | (6,295) | (3,981) |
Currency exchange differences relating to joint ventures | 169 | (311) |
Balance at the end of the year | (3,646) | 2,480 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Balance at the beginning of the year | 10,911 | 6,552 |
Losses on contract maturity recognised in revenue during the year | 19,176 | 133 |
Revaluations during the year | (13,372) | 5,679 |
Deferred tax movement | (1,451) | (1,453) |
Balance at the end of the year | 15,264 | 10,911 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Balance at the beginning of the year | (577) | (577) |
Share of profit for the year | – | – |
Balance at the end of the year | (577) | (577) |
| 2025 | 2024 | ||
| £’000 | £’000 | ||
Freehold land and buildings | 13,856 | 26,199 | |
Plant and equipment | 6,411 | 16, | 206 |
Motor vehicles | 129 | 135 | |
Total committed capital expenditure | 20,396 | 42,540 |
| 2025 | 2024 | |
| £’000 | £’000 | |
Purchased goods and services from the Group during the year | 219 | 250 |
Sold goods and services to the Group during the year | 22,794 | 23,026 |
Interest paid from the Group during the year | 371 | 55 |
Paid dividends to the Group during the year | 1,500 | 498 |
Amounts owed to the Group at the year end | 223 | 243 |
Amounts owed by the Group at the year end | 17,4 62 | 11,422 |
| 2025 | 2024 | |||
| Revenue at constant exchange rates: | £’000 | £’000 | ||
Statutory revenue as reported | 713,044 | 691,301 | ||
Adjustment for forward contract (gains)/losses | (19,176) | (133) | ||
Adjustment to restate current year at previous year exchange rates | 23,119 | – | ||
Revenue at constant exchange rates | 716,987 | 6 | 91,16 | 8 |
Year-on-year revenue growth at constant exchange rates | 3.7% | – |
| 2025 | 2024 | |
| Adjusted profit before tax: | £’000 | £’000 |
Statutory profit before tax | 118,000 | 122,594 |
Closure of drug delivery business | 2,059 | – |
Closure of the Edinburgh research facility | 2,320 | – |
Other interest payable on historical and non-recurring tax matters | 4,852 | – |
Adjusted profit before tax | 127, 231 | 122,594 |
| 2025 | 2024 | |
| Adjusted earnings per share: | pence | pence |
Statutory earnings per share | 115.2 | 133.2 |
Closure of drug delivery business (netoftax) | 2.1 | – |
Closure of the Edinburgh research facility (net of tax) | 2.4 | – |
Other interest payable on historical and non-recurring tax matters (netoftax) | 5.5 | – |
Taxation prior year adjustments | 12.6 | – |
Adjusted earnings per share | 137.8 | 133.2 |
| 2025 | 2024 | |
| Adjusted operating profit: | £’000 | £’000 |
Statutory operating profit | 107,885 | 108,667 |
Closure of drug delivery business | 2,059 | – |
Closure of the Edinburgh research facility | 2,320 | – |
Other interest payable on historical and non-recurring tax matters | – | – |
Adjusted operating profit | 112,264 | 108,667 |
| 2025 | 2024 | |
| Manufacturing technologies | £’000 | £’000 |
Operating profit | 107,593 | 103,181 |
Closure of Edinburgh research facility | 2,320 | – |
Adjusted manufacturing technologies operating profit | 109,913 | 103,181 |
| 2025 | 2024 | |
| Analytical instruments and medical devices | £’000 | £’000 |
Operating profit | 292 | 5,486 |
Closure of drug delivery business | 2,059 | – |
Adjusted analytical instruments and medical devices operating profit | 2,351 | 5,486 |
| 2025 | 2024 | |
| Adjusted operating profit at constant exchange rates: | £’000 | £’000 |
Adjusted operating profit | 112,264 | 108,667 |
Adjustment for forward contract (gains)/losses | (19,176) | (133) |
Adjustment to restate current year at previous year exchange rates | 16,784 | – |
Adjusted operating profit at constant exchange rates | 109,872 | 108,534 |
Year-on-year adjusted operating profit increase at constant exchange rates | 1.2% | – |
| 2025 | 2024 | |
| Adjusted cash flow conversion from operating activities: | £’000 | £’000 |
Cash flows from operating activities | 147,896 | 124,079 |
Income taxes paid | 6,207 | 21,752 |
Purchase of property, plant and equipment and intangible assets | (56,558) | (74,774) |
Proceeds from sale of property, plant and equipment and intangible assets | 4,887 | 4,475 |
Adjusted cash flow from operating activities | 102,432 | 75,532 |
Adjusted cash flow conversion from operating activities | 91.2% | 69.5% |
| 2025 | 2024 | ||
| £’000 | £’000 | ||
Statutory profit after tax | 83,757 | 96,889 | |
Closure of drug delivery business (netoftax) | 1,544 | – | |
Closure of Edinburgh research facility (netoftax) | 1,740 | – | |
Other interest payable on historical and non-recurring tax matters (netoftax) | 4,026 | – | |
Prior year adjustment taxation charge on historical and non-recurring tax matters | 9,154 | – | |
Adjusted profit after tax | 100,221 | 96,889 | |
Bank interest receivable (net of tax) | (8,805) | (6,832) | |
Adjusted profit after tax before bank interest received | 91,416 | 9 | 0,057 |
| 2025 | 2024 | 2023 | |||
| Return on invested capital (ROIC): | £’000 | £’000 | £’000 | ||
Total non-current assets | 506,926 | 464,765 | 470,430 | ||
Total current assets | 628,300 | 586,618 | 573,107 | ||
Total current liabilities | (137,461) | (100,948) | (102,320) | ||
Less cash and cash equivalents | (87,420) | (122,293) | (81,388) | ||
Less bank deposits | (186,226) | (95,542) | (125,000) | ||
Invested capital | 724,118 | 732,6 | 00 | 734,8 | 29 |
Average invested capital | 728,359 | 733,715 | 670,869 | ||
Return on invested capital | 12.6% | 12.3% | 16.1% |